The ArcheMedX Team has developed the Ready platform, known for being the first predictive readiness measure in the clinical trials industry. This platform has facilitated over 1,000,000 user sessions and operates in more than 90 countries,
...
benefiting over 400,000 clinicians treating Central Nervous System conditions. The readiness measure is informed by a predictive engine that has analyzed over 70 million behavioral data points, enabling earlier operational decisions and improved clinical performance.
In the realms of Clinical Operations, Commercial Adoption, and Medical Education, tailored training solutions are offered to enhance site activation and accelerate trial delivery. The platform aids in risk identification, helping to mitigate trial risks while lowering costs. Insights drawn from behavioral science are leveraged to ensure that trial sponsors and CROs can deliver higher quality trials more efficiently.
